{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T10:07:05Z","timestamp":1773050825981,"version":"3.50.1"},"reference-count":46,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T00:00:00Z","timestamp":1758067200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,11,19]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>The role of NPM1 immunostaining as a surrogate marker for acute myeloid leukemia (AML) with nucleophosmin (NPM1) mutation (AML-NPM1) in leukemia cutis has not been investigated.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>NPM1 immunostaining was performed using a polyclonal antibody on leukemia cutis diagnosed in 2017-2024 of 15 patients with and 15 without the NPM1 mutation. Targeted next-generation sequencing assays were performed on the initial bone marrow biopsy specimens.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>There were 18 skin biopsy specimens from 15 patients (11 men, 4 women, 33-90 years, median: 66 years) with AML-NPM1. Thirteen (87%) patients had multiple lesions, often on the trunk and extremities. There were 8 and 10 skin biopsies done concurrently and after the bone marrow AML diagnosis, respectively. The time interval between AML-NPM1 diagnosis and leukemia cutis was 0 to 38 months (median, 1 month). NPM1 immunostaining was positive in 18 of 18 skin biopsy specimens of patients with AML-NPM1 with a leukemic infiltrate. NPM1 immunostaining was negative in 15 of 15 leukemia cutis specimens of patients with AML who had other molecular alterations not involving NPM1. The sensitivity and specificity of NPM1 immunostaining in detecting cutaneous AML-NPM1 infiltrate are 100% and 100%, respectively.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Although limited in number, our study shows that NPM1 immunostaining is sensitive and specific in detecting AML-NPM1\u2013mutated cells in skin.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/ajcp\/aqaf089","type":"journal-article","created":{"date-parts":[[2025,7,26]],"date-time":"2025-07-26T11:51:30Z","timestamp":1753530690000},"page":"712-720","source":"Crossref","is-referenced-by-count":1,"title":["Role of nucleophosmin 1 immunostain in detecting leukemia cutis of acute myeloid leukemia with\n                    <i>NPM1<\/i>\n                    mutation"],"prefix":"10.1093","volume":"164","author":[{"given":"Rossana N Lazcano","family":"Segura","sequence":"first","affiliation":[{"name":"Department of Pathology, Massachusetts General Brigham , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Nardi","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Hospital and Harvard Medical School , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1406-7981","authenticated-orcid":false,"given":"Mai P","family":"Hoang","sequence":"additional","affiliation":[{"name":"Department of Pathology, Massachusetts General Brigham , Boston, MA ,","place":["United States"]}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"286","published-online":{"date-parts":[[2025,9,17]]},"reference":[{"key":"2025111922464989600_CIT0001","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1002\/1097-0142(197304)31:4&lt;948::aid-cncr2820310428&gt;3.0.co;2-n","article-title":"Autopsy study of granulocytic sarcoma (chloroma) in patients with myelogenous leukemia, Hiroshima-Nagasaki 1949-1969","volume":"31","author":"Liu","year":"1973","journal-title":"Cancer."},{"key":"2025111922464989600_CIT0002","doi-asserted-by":"publisher","first-page":"1426","DOI":"10.1002\/1097-0142(19810915)48:6&lt;1426::aid-cncr2820480626&gt;3.0.co;2-g","article-title":"Granulocytic sarcoma: a clinicopathologic study of 61 biopsied cases","volume":"48","author":"Neiman","year":"1981","journal-title":"Cancer."},{"key":"2025111922464989600_CIT0003","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1007\/s00277-001-0412-9","article-title":"A comparative study on demographic, hematological, and cytogenetic findings and prognosis in acute myeloid leukemia with and without leukemia cutis","volume":"81","author":"Agis","year":"2002","journal-title":"Ann Hematol."},{"key":"2025111922464989600_CIT0004","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.3324\/haematol.2019.223032","article-title":"The prevalence of extramedullary acute myeloid leukemia detected by (18)FGD-PET\/CT: final results from the prospective PETAML trial","volume":"105","author":"Stolzel","year":"2020","journal-title":"Haematologica."},{"key":"2025111922464989600_CIT0005","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1001\/jamadermatol.2019.0052","article-title":"Association of leukemia cutis with survival in acute myeloid leukemia","volume":"155","author":"Wang","year":"2019","journal-title":"JAMA Dermatol"},{"key":"2025111922464989600_CIT0006","first-page":"223","article-title":"Clinical, histopathologic, and immunohistochemical correlations in leukemia cutis","volume":"13","author":"Su","year":"1994","journal-title":"Semin Dermatol"},{"key":"2025111922464989600_CIT0007","doi-asserted-by":"publisher","first-page":"614","DOI":"10.3346\/jkms.2013.28.4.614","article-title":"Clinical characteristics of 75 patients with leukemia cutis","volume":"28","author":"Kang","year":"2013","journal-title":"J Korean Med Sci."},{"key":"2025111922464989600_CIT0008","doi-asserted-by":"publisher","first-page":"e412","DOI":"10.3324\/haematol.2015.129346","article-title":"NPM1 mutation is associated with leukemia cutis in acute myeloid leukemia with monocytic features","volume":"100","author":"Luskin","year":"2015","journal-title":"Haematologica."},{"key":"2025111922464989600_CIT0009","doi-asserted-by":"publisher","first-page":"1566","DOI":"10.1038\/sj.leu.2404699","article-title":"Cytoplasmic mutated nucleophosmin (NPM) defines the molecular status of a significant fraction of myeloid sarcomas","volume":"21","author":"Falini","year":"2007","journal-title":"Leukemia."},{"key":"2025111922464989600_CIT0010","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1056\/NEJMoa041974","article-title":"Cytoplasmic nucleophosmin in acute myelogenous leukemia with a normal karyotype","volume":"352","author":"Falini","year":"2005","journal-title":"N Engl J Med."},{"key":"2025111922464989600_CIT0011","doi-asserted-by":"publisher","first-page":"1999","DOI":"10.1182\/blood-2006-03-007013","article-title":"Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemia","volume":"108","author":"Falini","year":"2006","journal-title":"Blood."},{"key":"2025111922464989600_CIT0012","doi-asserted-by":"publisher","first-page":"2696","DOI":"10.1182\/blood.2021012732","article-title":"Novel NPM1 exon 5 mutations and gene fusions leading to aberrant cytoplasmic nucleophosmin in AML","volume":"138","author":"Martelli","year":"2021","journal-title":"Blood."},{"key":"2025111922464989600_CIT0013","doi-asserted-by":"publisher","first-page":"4737","DOI":"10.1002\/cncr.24543","article-title":"Cytoplasmic localization of nucleophosmin in bone marrow blasts of acute myeloid leukemia patients is not completely concordant with NPM1 mutation and is not predictive of prognosis","volume":"115","author":"Konoplev","year":"2009","journal-title":"Cancer."},{"key":"2025111922464989600_CIT0014","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1002\/jha2.866","article-title":"Diagnostic utility of immunohistochemistry in detection of NPM1 mutations in acute myeloid leukemia with a patchy distribution","volume":"5","author":"Wei","year":"2024","journal-title":"EJHaem"},{"key":"2025111922464989600_CIT0015","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1136\/jclinpath-2015-203175","article-title":"Immunohistochemical detection of cytoplasmic nucleophosmin in formalin-fixed paraffin-embedded marrow trephine biopsies in acute myeloid leukaemia","volume":"69","author":"Lit","year":"2016","journal-title":"J Clin Pathol."},{"key":"2025111922464989600_CIT0016","doi-asserted-by":"publisher","first-page":"763","DOI":"10.4103\/0971-5916.192027","article-title":"Nucleophosmin mutation analysis in acute myeloid leukaemia: immunohistochemistry as a surrogate for molecular techniques","volume":"143","author":"Chopra","year":"2016","journal-title":"Indian J Med Res."},{"key":"2025111922464989600_CIT0017","doi-asserted-by":"crossref","first-page":"670","DOI":"10.3324\/haematol.2009.011817","article-title":"Can cytoplasmic nucleophosmin be detected by immunohistochemical staining of cell smears in acute myeloid leukemia","volume":"95","author":"Mattsson","year":"2010","journal-title":"Hematologica."},{"key":"2025111922464989600_CIT0018","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s12288-022-01518-0","article-title":"Frequency of nucleophosmin 1 expression by immunohistochemistry in acute myeloid leukemia","volume":"38","author":"Oravakandy","year":"2022","journal-title":"Indian J Hematol Blood Transfus"},{"key":"2025111922464989600_CIT0019","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1309\/AJCPCI1FFE2DRXIV","article-title":"Cytoplasmic expression of nucleophosmin accurately predicts mutation in the nucleophosmin gene in patients with acute myeloid leukemia and normal karyotype","volume":"133","year":"2010","journal-title":"Am J Clin Pathol."},{"key":"2025111922464989600_CIT0020","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.1038\/nm.3729","article-title":"Anchored multiplex PCR for targeted next-generation sequencing","volume":"20","author":"Zheng","year":"2014","journal-title":"Nat Med."},{"key":"2025111922464989600_CIT0021","volume-title":"R: A Language and Environment for Statistical Computing","author":"R Core Team","year":"2024"},{"key":"2025111922464989600_CIT0022","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1309\/WYACYWF6NGM3WBRT","article-title":"Leukemia cutis","volume":"129","author":"Cho-Vega","year":"2008","journal-title":"Am J Clin Pathol."},{"key":"2025111922464989600_CIT0023","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1001\/archderm.129.10.1301","article-title":"Leukemia cutis in congenital leukemia: analysis and review of the world literature with report of an additional case","volume":"129","author":"Resnik","year":"1993","journal-title":"Arch Dermatol."},{"key":"2025111922464989600_CIT0024","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1111\/j.1610-0387.2011.07842.x","article-title":"Leukemia cutis: epidemiology, clinical presentation, and differential diagnoses","volume":"10","author":"Wagner","year":"2012","journal-title":"J Dtsch Dermatol Ges."},{"key":"2025111922464989600_CIT0025","doi-asserted-by":"publisher","first-page":"adv00647","DOI":"10.2340\/actadv.v102.1123","article-title":"Leukaemia cutis: clinical features and outcomes of 56 patients","volume":"102","author":"Yook","year":"2022","journal-title":"Acta Derm Venereol."},{"key":"2025111922464989600_CIT0026","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.jaad.2008.11.888","article-title":"Leukemic vasculitis. An unusual manifestation of leukemia cutis","volume":"61","author":"Seckin","year":"2009","journal-title":"J Am Acad Dermatol."},{"key":"2025111922464989600_CIT0027","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1186\/s13045-022-01267-7","article-title":"Molecular profiling and clinical implications of patients with acute myeloid leukemia and extramedullary manifestations","volume":"15","author":"Eckardt","year":"2022","journal-title":"J Hematol Oncol"},{"key":"2025111922464989600_CIT0028","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1080\/10428190600967196","article-title":"Granulocytic sarcoma: 32 cases and review of the literature","volume":"47","author":"Paydas","year":"2006","journal-title":"Leuk Lymphoma."},{"key":"2025111922464989600_CIT0029","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1056\/NEJMoa1301689","article-title":"Genomic and epigenomic landscapes of adult de novo acute myeloid leukemia","volume":"368","author":"Ley","year":"2013","journal-title":"N Engl J Med."},{"key":"2025111922464989600_CIT0030","doi-asserted-by":"publisher","first-page":"1703","DOI":"10.1038\/s41375-022-01613-1","article-title":"The 5th edition of the World Health Organization Classification of haematolymphoid tumours: myeloid and histiocytic\/dendritic neoplasms","volume":"36","author":"Khoury","year":"2022","journal-title":"Leukemia."},{"key":"2025111922464989600_CIT0031","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1182\/blood.2022015851","article-title":"The International Consensus Classification of mature lymphoid neoplasms: a report from the clinical advisory committee","volume":"140","author":"Campo","year":"2022","journal-title":"Blood."},{"key":"2025111922464989600_CIT0032","doi-asserted-by":"publisher","first-page":"1707","DOI":"10.1182\/blood.2019004226","article-title":"NPM1-mutated acute myeloid leukemia: from bench to bedside","volume":"136","author":"Falini","year":"2020","journal-title":"Blood."},{"key":"2025111922464989600_CIT0033","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1080\/10428194.2023.2185091","article-title":"Myeloid sarcoma with NPM1 mutation may be clinically and genetically distinct from AML with NPM1 mutation: a study from the Bone Marrow Pathology Group","volume":"64","author":"Ramia de Cap","year":"2023","journal-title":"Leuk Lymphoma."},{"key":"2025111922464989600_CIT0034","doi-asserted-by":"publisher","first-page":"1953","DOI":"10.1038\/leu.2014.90","article-title":"The prognostic relevance of flt3 and npm1 mutations on older patients treated intensively or non-intensively: a study of 1312 patients in the UK NCRI AML16 trial","volume":"28","author":"Lazenby","year":"2014","journal-title":"Leukemia."},{"key":"2025111922464989600_CIT0035","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1111\/ejh.12549","article-title":"Chronic myelomonocytic leukemia with nucleophosmin (NPM1) mutation","volume":"96","author":"Peng","year":"2016","journal-title":"Eur J Haematol."},{"key":"2025111922464989600_CIT0036","doi-asserted-by":"publisher","first-page":"100352","DOI":"10.1016\/j.modpat.2023.100352","article-title":"Cutaneous manifestations of myeloid neoplasms exhibit broad and divergent morphologic and immunophenotypic features but share ancestral clonal mutations with bone marrow","volume":"37","author":"Sadigh","year":"2024","journal-title":"Mod Pathol."},{"key":"2025111922464989600_CIT0037","doi-asserted-by":"publisher","first-page":"3880","DOI":"10.1002\/cncr.34459","article-title":"Molecular annotation of extramedullary acute myeloid leukemia identifies high prevalence of targetable mutations","volume":"128","author":"Ball","year":"2022","journal-title":"Cancer."},{"key":"2025111922464989600_CIT0038","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/ncb814","article-title":"Nucleophosmin regulates the stability and transcriptional activity of p53","volume":"4","author":"Colombo","year":"2002","journal-title":"Nat Cell Biol."},{"key":"2025111922464989600_CIT0039","doi-asserted-by":"publisher","first-page":"9327","DOI":"10.1128\/MCB.24.21.9327-9338.2004","article-title":"ARF impedes NPM\/B23 shuttling in an Mdm2-sensitive tumor suppressor pathway","volume":"24","author":"Brady","year":"2004","journal-title":"Mol Cell Biol."},{"key":"2025111922464989600_CIT0040","doi-asserted-by":"publisher","first-page":"24451","DOI":"10.1074\/jbc.M003278200","article-title":"Mapping the functional domains of nucleolar protein B23","volume":"275","author":"Hingorani","year":"2000","journal-title":"J Biol Chem."},{"key":"2025111922464989600_CIT0041","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1042\/bj3290539","article-title":"Evidence for the ability of nucleophosmin\/B23 to bind ATP","volume":"329(pt 3)","author":"Chang","year":"1998","journal-title":"Biochem J."},{"key":"2025111922464989600_CIT0042","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1093\/oxfordjournals.jbchem.a002973","article-title":"The carboxyl terminal sequence of nucleolar protein B23.1 is important in its DNA polymerase alpha-stimulatory activity","volume":"130","author":"Umekawa","year":"2001","journal-title":"J Biochem."},{"key":"2025111922464989600_CIT0043","doi-asserted-by":"publisher","first-page":"4514","DOI":"10.1182\/blood-2005-11-4745","article-title":"Both carboxy-terminus NES motif and mutated tryptophan(s) are crucial for aberrant nuclear export of nucleophosmin leukemic mutants in NPMc+AML","volume":"107","author":"Falini","year":"2006","journal-title":"Blood."},{"key":"2025111922464989600_CIT0044","doi-asserted-by":"publisher","first-page":"1760","DOI":"10.1038\/sj.leu.2403899","article-title":"Cell line OCI\/AML3 bears exon-12 NPM gene mutation-A and cytoplasmic expression of nucleophosmin","volume":"19","author":"Quentmeier","year":"2005","journal-title":"Leukemia."},{"key":"2025111922464989600_CIT0045","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1159\/000531101","article-title":"Acute myeloid leukemia with NPM1 mutation and disseminated leukaemia cutis: achievement of molecular complete remission by venetoclax\/azacytidine combination in a very old patient","volume":"146","author":"Niscola","year":"2023","journal-title":"Acta Haematol."},{"key":"2025111922464989600_CIT0046","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.3324\/haematol.2012.079806","article-title":"A single center analysis of nucleophosmin in acute myeloid leukemia: value of combining immunohistochemistry with molecular mutation analysis","volume":"98","author":"Woolthuis","year":"2013","journal-title":"Haematologica."}],"container-title":["American Journal of Clinical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/164\/5\/712\/64302039\/aqaf089.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ajcp\/article-pdf\/164\/5\/712\/64302039\/aqaf089.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T03:46:59Z","timestamp":1763610419000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ajcp\/article\/164\/5\/712\/8256643"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,9,17]]},"references-count":46,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2025,9,17]]},"published-print":{"date-parts":[[2025,11,19]]}},"URL":"https:\/\/doi.org\/10.1093\/ajcp\/aqaf089","relation":{},"ISSN":["0002-9173","1943-7722"],"issn-type":[{"value":"0002-9173","type":"print"},{"value":"1943-7722","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,11]]},"published":{"date-parts":[[2025,9,17]]}}}